Project Details
Description
Will seek to identify how ketamine, a rapid-acting, still experimental antidepressant, impacts the hippocampus in mice models of depression. Her lab has developed a transgenic mouse that can permanently label neurons activated by a particular experience to reveal how hippocampal function is impaired in depression and how ketamine affects hippocampal circuits to alleviate depressive-like symptoms in the mice.
Status | Active |
---|---|
Effective start/end date | 1/1/14 → … |
Funding
- Brain and Behavior Research Foundation
ASJC Scopus Subject Areas
- Medicine(all)
- Social Sciences(all)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.